DrugDashboards

Glipizide and Metformin Hydrochloride

Glipizide and Metformin Hydrochloride · METFORMIN HYDROCHLORIDE 500 mg/1; GLIPIZIDE 5 mg/1 · Tablet, Film Coated · Oral · Remedyrepack Inc.

NDC 70518-0373-00 · 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC · ANDA · View full market →

The short version

6 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for glipizide and metformin hydrochloride (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA077270
TE code
AB
Approval date
Oct 28, 2005
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Glipizide and Metformin Hydrochloride (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsGLIPIZIDE 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg/1Jul 15, 2026Sep 2, 2026
A-S Medication SolutionsGLIPIZIDE 2.5 mg/1; METFORMIN HYDROCHLORIDE 500 mg/1Jul 15, 2026Sep 2, 2026
AvKAREGLIPIZIDE 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg/1Jul 15, 2026Sep 2, 2026
AvKAREGLIPIZIDE 2.5 mg/1; METFORMIN HYDROCHLORIDE 500 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.METFORMIN HYDROCHLORIDE 500 mg/1; GLIPIZIDE 5 mg/1Aug 26, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.GLIPIZIDE 2.5 mg/1; METFORMIN HYDROCHLORIDE 250 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.GLIPIZIDE 2.5 mg/1; METFORMIN HYDROCHLORIDE 500 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.GLIPIZIDE 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedGLIPIZIDE 2.5 mg/1; METFORMIN HYDROCHLORIDE 250 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedGLIPIZIDE 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedGLIPIZIDE 2.5 mg/1; METFORMIN HYDROCHLORIDE 500 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.GLIPIZIDE 2.5 mg/1; METFORMIN HYDROCHLORIDE 500 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.GLIPIZIDE 2.5 mg/1; METFORMIN HYDROCHLORIDE 250 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.GLIPIZIDE 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.METFORMIN HYDROCHLORIDE 5 mg/1; GLIPIZIDE 500 mg/1Jul 22, 2026Aug 19, 2026
Remedyrepack Inc.GLIPIZIDE 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Glipizide and Metformin Hydrochloride — NDC 70518-0373-00," retrieved September 3, 2026, https://drugdashboards.com/drug/70518037300.

Free to cite with attribution — see how the data is put together.